Tag
2 articles
This article explains how a scaffold-split Random Forest QSAR model, combined with tools like ChEMBL, RDKit, SHAP, and BRICS, can autonomously identify and design novel EGFR inhibitors, demonstrating advanced AI applications in drug discovery.
NVIDIA's new BioNeMo Agent Toolkit turns biomolecular models into callable AI skills, significantly boosting task completion rates in drug discovery.